Drug Information Update – FDA approves new treatment for rare metabolic disorder

Drug Information Update – FDA approves new treatment for rare metabolic disorder FDA Division of Drug Information: Know the Moment It Happens The Division of Drug Information (DDI) is CDER’s focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA. On October 23,Continue reading “Drug Information Update – FDA approves new treatment for rare metabolic disorder”